Mobile

A Study to Compare ABT-494 Monotherapy to Methotrexate Monotherapy in Subjects with Rheumatoid Arthritis (RA) Who have not Previously taken Methotrexate (SELECT-EARLY)

Mise à jour : Il y a 4 ans
Référence : EUCTR2015-003334-27

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

• To compare the safety and efficacy of ABT-494 monotherapy versus methotrexate (MTX) monotherapy for the treatment of signs and symptoms of rheumatoid arthritis (RA) in MTX-naïve subjects with moderately to severely active RA. • To compare the efficacy of ABT-494 monotherapy versus MTX monotherapy for prevention of structural progression in MTX-naive subjects with moderately to severely active RA. • To evaluate the long-term safety, tolerability, and efficacy of ABT-494 in subjects with RA.

Critère d'inclusion

  • Moderately to Severely Active Rheumatoid Arthritis (RA)

Liens